Featured Articles

  1. The Need For Mass Produced Spheroids 10/26/2023

    Researchers looking for reliable ways to recapitulate physiological conditions are turning to spheroids and other 3D objects, seeking ways to mass-produce 3D models for various applications.

  2. What To Know About CRISPR Screens And Bulk Spheroid Production 10/24/2023

    Achieve a more physiologically relevant setting with less reliance on model animals when studying diseases like cancer through the combination of CRISPR screening and bulk spheroid production.

  3. Trends In Precision Medicine: Cancer 10/24/2023

    Scientists are working to discover new and effective ways precision medicine can prevent, diagnose, and treat diseases such as cancer.

  4. Guide To Seeding, Expanding, And Harvesting Stem Cells 9/5/2023

    Investigate important considerations for working with three different stem cell types: mesenchymal stem/stromal cells, induced pluripotent stem cells, and neural stem cells.

  5. Cryopreservation In Stem Cell Therapy 9/5/2023

    The cryopreservation process maintains the structural integrity of living cells, but what other information is crucial for manufacturers when considering cryopreservation and its impact on cell-based therapies?

  6. 6 Questions To Ask When Vetting Serum Suppliers 9/5/2023

    There are some pointed questions that manufacturers need to ask their suppliers before stocking or restocking serums in their lab. Here are six they can start with.

  7. Sustainable Solutions For Labs Offer A Greener Choice 9/5/2023

    Sustainable solutions are being explored by manufacturers to combat waste during biomedical research and reduce the environmental impact of labs.

  8. A Guide To Adherent Scale-Up 9/5/2023

    Biomanufacturers looking to take advantage of the ongoing biomedical revolution and new treatments can benefit from platform solutions utilized in scaling-up adherent cell cultures.

  9. How CDMOs Have Become Emerging Technology Influencers 3/20/2023

    Learn how CDMOs fill the gap between cutting-edge science and the commercial sector of cell-and-gene therapeutics by partnering with the best technology providers to maximize the manufacturing process.

  10. Allogeneic Cell Therapy: What Options Do Sponsors Have To Scale? 2/1/2023

    Explore some automated scale-up solutions and how you can design and execute your allogeneic cell therapy seed chain from phase 1 onward.